Suregene, LLC

Louisville, KY 40299

SBIR Award Summary

Total Number of Awards 5
Total Value of Awards $1.6MM
First Award Date 09/26/06
Most Recent Award Date 04/01/11

Key Personnel

Last Name Name Awards Contact
Brennan Mark David Brennan 5

5 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-016
Budget: 04/01/11 - 09/30/12

DESCRIPTION (provided by applicant): The long-term objective of this project is to develop validated, genetic biomarkers to aid in more accurate diagnosis and targeted treatment of schizophrenia and related neuropsychiatric illnesses, including bipolar disorder. In Phase I, SureGene demonstrated the feasibility of using specific dimensions of m...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-016
Budget: 04/01/10 - 03/31/11

DESCRIPTION (provided by applicant): The long-term objective of this project is to develop validated, genetic biomarkers to aid in more accurate diagnosis and targeted treatment of schizophrenia and related neuropsychiatric illnesses, including bipolar disorder. In Phase I, SureGene demonstrated the feasibility of using specific dimensions of m...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-016
Budget: 04/01/09 - 03/31/10

DESCRIPTION (provided by applicant): The long-term objective of this project is to develop validated, genetic biomarkers to aid in more accurate diagnosis and targeted treatment of schizophrenia and related neuropsychiatric illnesses, including bipolar disorder. In Phase I, SureGene demonstrated the feasibility of using specific dimensions of m...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-16
Budget: 09/01/07 - 08/31/08

DESCRIPTION (provided by applicant): The long term objective of this project is to develop validated, genotype-based biomarkers to aid in more accurate diagnosis of schizophrenia and related schizophrenia spectrum disorders, including bipolar disorder. SureGene, LLC is developing two novel genetic tests, one based on the SULT4A1 gene on chromoso...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-16
Budget: 09/26/06 - 08/31/07

DESCRIPTION (provided by applicant): The long term objective of this project is to develop validated, genotype-based biomarkers to aid in more accurate diagnosis of schizophrenia and related schizophrenia spectrum disorders, including bipolar disorder. SureGene, LLC is developing two novel genetic tests, one based on the SULT4A1 gene on chromoso...